Skip to main content

Articles

Page 1 of 8

  1. The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of th...

    Authors: Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, Yusuff Adebayo Adebisi, Mustafa Hayder Kadhim, Mohammad Yasir Essar, Shoaib Ahmad and Don Eliseo Lucero-Prisno III

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:17

    Content type: Commentary

    Published on:

  2. Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to...

    Authors: Gloria Twesigye, Tamara Hafner and Javier Guzman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:16

    Content type: Commentary

    Published on:

  3. COVID-19 is a threat to health systems around the world and Rwanda is not an exception. The impact of the pandemic is far-reaching and access to health commodities is not spared. Proper drug supply is critical...

    Authors: Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, Remy Ndayizeye, Yusuff Adebayo Adebisi and Don Eliseo Lucero-Prisno III

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:12

    Content type: Commentary

    Published on:

  4. The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to...

    Authors: Ali Elbeddini, Sarah Almasalkhi, Thulasika Prabaharan, Cindy Tran, Mohamed Gazarin and Ahmed Elshahawi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:10

    Content type: Research

    Published on:

  5. Antimicrobial agents are among the most commonly prescribed drugs in pregnancy due to the increased susceptibility to infections during pregnancy. Antimicrobials can contribute to different maternal complicati...

    Authors: Mohamed A. Baraka, Lina Hussain AlLehaibi, Hind Nasser AlSuwaidan, Duaa Alsulaiman, Md. Ashraful Islam, Badriyah Shadid Alotaibi, Amany Alboghdadly, Ali H. Homoud, Fuad H. Al-Ghamdi, Mastour S. Al Ghamdi and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:9

    Content type: Research

    Published on:

  6. Research has shown that there is an increase in the global prevalence of asthma. Pharmacists are well positioned to screen and refer patients for better management of asthma. This study aimed to evaluate commu...

    Authors: Sanah Hasan, Lujain Al Oum and Nageeb AbdulGalil Hassan

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:8

    Content type: Research

    Published on:

  7. The pharmaceutical technology unit of the Geneva University Hospitals played a significant role in the fight against COVID-19 through four different missions: (1) providing enough hydroalcoholic solution at th...

    Authors: Alexandra Garnier, Ludivine Falaschi, Pascal Bonnabry and Lucie Bouchoud

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:7

    Content type: Letter to the editor

    Published on:

  8. Spontaneous reporting of adverse drug reactions (ADRs) is a method of monitoring the safety of drugs and is the basic strategy for the post-marketing surveillance of the suspected drugs. Despite its importance...

    Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Tayyaba Akram

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:5

    Content type: Research

    Published on:

  9. Changing demographics across the UK has led to general practitioners (GPs) managing increasing numbers of older patients with multi-morbidity and resultant polypharmacy. Through government led initiatives with...

    Authors: Nadia Farhanah Syafhan, Sayer Al Azzam, Steven D. Williams, Wendy Wilson, Jayne Brady, Peter Lawrence, Mark McCrudden, Mustafa Ahmed, Michael G. Scott, Glenda Fleming, Anita Hogg, Claire Scullin, Robert Horne, Harblas Ahir and James C. McElnay

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:4

    Content type: Research

    Published on:

  10. Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have the...

    Authors: Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim and Aidan Hollis

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:3

    Content type: Research

    Published on:

  11. Acute bronchiolitis is the leading cause of hospitalization in the pediatric population. The inappropriate prescription of antibiotics in acute bronchiolitis is associated with bacterial resistance, higher cos...

    Authors: Jefferson Antonio Buendía and John Edwin Feliciano-Alfonso

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:2

    Content type: Research

    Published on:

  12. The coronavirus disease 19 (COVID-19) pandemic is putting a huge strain on healthcare systems and is a turning point for the beginning of a global health crisis of an unprecedented condition. As such, the prov...

    Authors: Gemmechu Hasen, Rashed Edris, Gadisa Chala, Yesuneh Tefera, Hawi Hussen, Tamirat Tekassa and Sultan Suleman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:1

    Content type: Commentary

    Published on:

  13. When the first wave of COVID-19 hit in March 2020, health care professionals across Canada were challenged to quickly and efficiently adapt to change their work practices in these unprecedented times. Pharmacy...

    Authors: Ali Elbeddini, Amy Botross, Rachel Gerochi, Mohamed Gazarin and Ahmed Elshahawi

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:76

    Content type: Commentary

    Published on:

  14. The digitalization of health and medicine and the growing availability of electronic health records (EHRs) has encouraged healthcare professionals and clinical researchers to adopt cutting-edge methodologies i...

    Authors: Carlos Del Rio-Bermudez, Ignacio H. Medrano, Laura Yebes and Jose Luis Poveda

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:75

    Content type: Commentary

    Published on:

  15. In Lebanon, difficulties in accessing medications are due to two main barriers, mainly: high cost and the lack of medication safety, related to poor-quality (irrational) prescription and use. The objective of ...

    Authors: Aline Hajj, Hala Sacre, Souheil Hallit, Rony M. Zeenny, Georges Sili and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:70

    Content type: Short report

    Published on:

  16. The coronavirus disease 19 (COVID-19) is rapidly spreading across the world. Pharmacy services play a vital role in public health in preventing and containing the COVID-19 pandemic. All over the world, especia...

    Authors: Kashif Hussain, Gul Ambreen, Mehreen Muzammil, Syed Shamim Raza and Umer Ali

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:74

    Content type: Commentary

    Published on:

  17. Smoking cessation pharmacotherapies (SCPs) have been established as cost-effective for the treatment of tobacco use disorder across a variety of settings. In Jordan, a resource-constrained country where smokin...

    Authors: Saba Madae’en, Nour Obeidat and Mohammad Adeinat

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:65

    Content type: Policy analysis

    Published on:

  18. Canada has been home to comparatively extreme developments in prescription opioid (PO) availability and related harms (e.g. morbidity, mortality) post-2000. Following persistent pan-Canadian increases in PO us...

    Authors: Wayne Jones, Lenka Vojtila, Paul Kurdyak and Benedikt Fischer

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:68

    Content type: Short report

    Published on:

  19. The declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries acr...

    Authors: Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:72

    Content type: Research

    Published on:

  20. Medical products are an integral and pivotal part of health care delivery. They need to be available, affordable and quality-assured. The SADC region is prone to threats arising from the availability and use o...

    Authors: Stanislav Kniazkov, Sakhile Dube-Mwedzi and Jean-Baptiste Nikiema

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:71

    Content type: Review

    Published on:

  21. Little is known about how much public payers spend on orphan medicines. This study aimed at identifying information on orphan medicine expenditure incurred by public payers that was published in literature glo...

    Authors: Margit Gombocz and Sabine Vogler

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:66

    Content type: Research

    Published on:

  22. A dispensing error can be defined as an inconsistency between the drug prescribed and drug dispensed to a patient. These errors can lead to ineffective and sometimes unwanted pharmaceutical outcomes. Dispensin...

    Authors: Sandeep Maharaj, Adrian Brahim, Horry Brown, Danielle Budraj, Vatalie Caesar, Anyse Calder, Deisha Carr, Dion Castillo, Kevin Cedeno and Manthan D. Janodia

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:67

    Content type: Research

    Published on:

  23. Medications are crucial for maintaining patient wellness and improving health in modern medicine, but their use comes with risks. Helping patients to understand why they are taking medications is important for...

    Authors: Colin Whaley, Ashley Bancsi, Joanne Man-Wai Ho, Catherine M. Burns and Kelly Grindrod

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:63

    Content type: Research

    Published on:

  24. Antibiotic resistance (ABX-R) is alarming in lower/middle-income countries (LMICs). Nonadherence to antibiotic guidelines and inappropriate prescribing are significant contributing factors to ABX-R. This study...

    Authors: Kashif Hussain, Muhammad Faisal Khan, Gul Ambreen, Syed Shamim Raza, Seema Irfan, Kiren Habib and Hasnain Zafar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:69

    Content type: Research

    Published on:

  25. Access to quality-assured, safe and efficacious medical products is fundamental for Universal Health Coverage and attaining Sustainable Development Goal 3: Ensure Healthy Lives and Well-being for All. To guara...

    Authors: S. Dube-Mwedzi, S. Kniazkov, J. B. Nikiema, O. M. J. Kasilo, A. Fortin, P. Tumusiime, G. N. Mahlangu and M. Ndomondo-Sigonda

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:64

    Content type: Review

    Published on:

  26. Due to a liberalisation reform in 2009, the availability of over-the-counter (OTC) analgesics has increased significantly in the Swedish market over the past decade. With the increasing number of generic produ...

    Authors: Helle Håkonsen, Maria Wängberg, Dina Alani and Tove Hedenrud

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:60

    Content type: Research

    Published on:

  27. In Switzerland, the influenza vaccination is recommended for high-risk groups and people who have contact with high-risk groups. Since 2015, Swiss pharmacists are allowed to vaccinate healthy adults after acqu...

    Authors: Dominik Stämpfli, Adrian Martinez-De la Torre, Sophie Du Pasquier, Danielle Stegmann, Andrea Brügger and Andrea M. Burden

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:57

    Content type: Research

    Published on:

  28. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The nature of healthcare providers’ occupation puts them at an increased risk of getting any contagious disease...

    Authors: Abdullah Algunmeeyn, Faris El-Dahiyat, Mohammad Mitib Altakhineh, Mohammad Azab and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:53

    Content type: Research

    Published on:

  29. With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antivira...

    Authors: Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski and Aleksandra Grozdanova

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:61

    Content type: Commentary

    Published on:

  30. During the COVID-19 pandemic, the Lebanese government has taken the proactive anticipatory measure to minimize the infection rates. Despite the pivotal role of the pharmacists working in hospital settings, hos...

    Authors: Rony M. Zeenny, Elsy Ramia, Youssef Akiki, Souheil Hallit and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:54

    Content type: Research

    Published on:

  31. The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as a challenge for many countries globally is how to ensure the efficient and effective procurement of q...

    Authors: Jillian Clare Kohler and Tom Wright

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:58

    Content type: Commentary

    Published on:

  32. Regulatory inspection of private drug shops in Uganda is a mandate of the Ministry of Health carried out by the National Drug Authority. This study evaluated how this mandate is being carried out at national, ...

    Authors: Arthur Bagonza, Stefan Peterson, Andreas Mårtensson, Henry Wamani, Phyllis Awor, Milton Mutto, David Musoke, Linda Gibson and Freddy Eric Kitutu

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:55

    Content type: Research

    Published on:

  33. The Caribbean Regulatory System is a centralized medicine assessment procedure established to serve the needs of the Member States of the CARICOM region. In order to better understand the effectiveness and eff...

    Authors: Lawrence Liberti, Rian Marie Extavour, Prisha Patel and Neil McAuslane

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:56

    Content type: Research

    Published on:

  34. Maintaining an efficient and effective inventory management system ensures a reliable supply of laboratory commodities. The aim of this study was, therefore, to assess the performance of inventory management f...

    Authors: Abdi Befekadu, Waqtola Cheneke, Dereje Kebebe and Tadesse Gudeta

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:49

    Content type: Research

    Published on:

  35. To strengthen appropriate medicine use (AMU) including the prescribing and dispensing quality at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged approach known as th...

    Authors: Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner and Dennis Ross-Degnan

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:48

    Content type: Research

    Published on:

  36. Iranian government has introduced multiple healthcare system reforms during the last 30 years aiming at improving accessibility and affordability of care. Pharmaceutical products are one of the major sources o...

    Authors: Saman Zartab, Nasrin Nassiri Koopaei, Hadi Abbasian, Mansur Nassiri Koopaei and Nasser Nassiri Koopaei

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:50

    Content type: Research

    Published on:

  37. Most pharmacists agree that continuing education (CE) programs positively affect their practice and increase their knowledge, with computer-based courses being their preferred type of CE (60.6%). The route to ...

    Authors: Souheil Hallit, Samah Tawil, Hala Sacre, Clara Rahme, Aline Hajj and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:44

    Content type: Research

    Published on:

  38. This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and...

    Authors: F. Alves da Costa, M. Henman, C. Hughes, H. Leufkens, Z. Babar, J. McElnay and M. Schulz

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:51

    Content type: Obituary

    Published on:

  39. Amiodarone is known for its efficacy as an antiarrhythmic agent; however, its extensive side-effect profile requires careful selection of patients and frequent monitoring. The purpose of this study was to eval...

    Authors: Bander Ahmed Albassam, Nouf Mohammed Almutairi, Sarah Fahad Aldosari and Hind Saleh Almodaimegh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:37

    Content type: Research

    Published on:

  40. In March 2020, the World Health Organization (WHO) declared the coronavirus infectious disease as a pandemic referred to as COVID-19. As an essential service, community pharmacists have been enacting a key rol...

    Authors: Iman A. Basheti, Razan Nassar, Muna Barakat, Rajaa Alqudah, Rana Abu Farha, Tareq Muqatash, Samar Thiab and Bandana Saini

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:62

    Content type: Research

    Published on:

  41. Empathy is the cornerstone of the relationship between the healthcare provider and the patient. In Lebanon, no studies have investigated the factors associated with empathy among community pharmacists. Hence, ...

    Authors: Eva Hobeika, Souheil Hallit, Hala Sacre, Sahar Obeid, Aline Hajj and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:32

    Content type: Research

    Published on:

  42. Universal access to high quality essential medicines is critical to sustainable development (SDG 3.8). However low- and middle-income countries struggle to ensure access to all medicines on their national esse...

    Authors: Petra Brhlikova, Karen Maigetter, Jude Murison, Amon G. Agaba, Jonans Tusiimire and Allyson M. Pollock

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:31

    Content type: Research

    Published on:

  43. Resistant strains of bacteria are rapidly emerging with increasing inappropriate use of antibiotics rendering them less efficacious. Self-purchasing of antibiotics particularly for viral infections is a key dr...

    Authors: Zikria Saleem, Mohamed Azmi Hassali, Brian Godman, Munazzah Fatima, Zeenia Ahmad, Areeba Sajid, Inaam Ur Rehman, Muhammad Umer Nadeem, Zaida Javaid, Madeeha Malik and Azhar Hussain

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:26

    Content type: Research

    Published on:

  44. Since SARS-CoV2 was declared a Public Health Emergency of International Concern, those tasked with the stewardship of public health at a global, regional, and local level—policymakers, politicians, scientists, dr...

    Authors: Jerome Amir Singh and Rafaella Ravinetto

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:47

    Content type: Commentary

    Published on:

  45. There is limited published data form Pakistan on treatment success rate among extrapulmonary tuberculosis (EPTB) patients. The aim of this study was to assess clinical form, treatment outcomes, and identify th...

    Authors: Muhammad Atif, Razia Fatima, Nafees Ahmad and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:35

    Content type: Research

    Published on:

Annual Journal Metrics